Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experimental diabetes induces functional and structural changes in the peritoneum.

Maria S Stoenoiu1, An S De Vriese, Agnes Brouet

  • 1Department of Nephrology, Université Catholique de Louvain Medical School, Brussels, Belgium.

Kidney International
|July 12, 2002
PubMed
Summary

Diabetes and hyperglycemia cause peritoneal membrane changes in rats, including increased permeability. Insulin treatment prevented these alterations, suggesting good diabetes control preserves peritoneal membrane integrity for dialysis patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI automated grid placement in the OMERACT knee inflammation MRI scoring system (KIMRISS) for bone marrow lesion assessment: A multi-reader exercise.

Seminars in arthritis and rheumatism·2026
Same author

Structural damage assessment in the spine of patients with axial spondyloarthritis - results from an international OMERACT multi-reader exercise using MRI-based synthetic CT.

Seminars in arthritis and rheumatism·2026
Same author

Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial.

JAMA·2026
Same author

Hypertension in autoimmune rheumatic diseases: a position paper from the European Society of Hypertension working group on small arteries. Part A: pathophysiology, prevalence and cardiovascular risk estimation.

Journal of hypertension·2026
Same author

Hypertension in autoimmune rheumatic diseases - a position paper from the European Society of Hypertension working group on small arteries. Part B: Recommendations for the clinical management of hypertension.

Journal of hypertension·2026
Same author

Anti-CD38 Therapy With Daratumumab in High-Risk IgA Nephropathy.

Kidney international reports·2026

Area of Science:

  • Nephrology
  • Endocrinology
  • Vascular Biology

Background:

  • Peritoneal dialysis (PD) is a renal replacement therapy for diabetic patients.
  • The impact of diabetes on the peritoneal membrane (PM) is not fully understood.
  • This study investigates diabetes-induced changes in the PM.

Purpose of the Study:

  • To elucidate the functional, biochemical, and molecular changes in the peritoneal membrane (PM) induced by diabetes and hyperglycemia.
  • To assess the role of insulin and hyperosmolality in these PM alterations.

Main Methods:

  • Induction of diabetes in rats using streptozotocin (STZ).
  • Peritoneal equilibration tests, morphological analyses, and measurement of nitric oxide synthase (NOS) activities and advanced glycation end products (AGEs).

Related Experiment Videos

  • In vivo studies with insulin treatment and in vitro studies using bovine aortic endothelial cells (BAEC).

    • Main Results:

    • Diabetic rats showed increased PM permeability, capillary proliferation, and elevated endothelial NOS (eNOS) and AGEs.
    • NOS activity increased, with eNOS up-regulation and neuronal NOS down-regulation.
    • Changes were prevented by insulin treatment; hyperosmolality alone had no effect.

    Conclusions:

    • Chronic hyperglycemia induces functional and structural changes in the peritoneum, linked to NOS isoform regulation and AGE deposition.
    • Insulin treatment preserves PM integrity, highlighting the importance of diabetes control.
    • These findings suggest that managing diabetes can protect the peritoneal membrane in patients undergoing PD.